United Kingdom· GB-APID-715911000001107
Lariam 250mg tablets
A mefloquine product containing mefloquine, registered in United Kingdom by Neon Healthcare Ltd. The same ATC class is registered in 9 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Mefloquine is registered in 9 of 19 countries.
Countries holding a registration under ATC P01BC02 (mefloquine), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 5 of them publish a price we can compare per daily dose
Mefloquine · ATC P01BC02
9 / 19 countries
- Belgiumprice
- Canada
- Finlandprice
- Japan
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Mefloquine
- Manufacturer
- Neon Healthcare Ltd
- Country
- United Kingdom (GB)
- ATC code
- P01BC02
- ATC class
- Mefloquine
- Defined daily dose
- 1 g, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 3
- gtin5000471002690
- gtin4260095681898
- gtin5060499390513
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
439 interactions on record for mefloquine.
Graded by severity as the source publishes them — 82 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Mefloquine · interactions on record
439 records
- 82 severe
- 338 moderate
- 8 minor
- 11 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- ProcainamideC01BA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Mefloquine in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsLariam 250 mg, tablettenEU-Pharma B.V.
- United StatesMefloquine HydrochlorideTeva Pharmaceuticals USA, Inc.
- FinlandLariamParanova Oy
- CanadaMEFLOQUINEAA PHARMA INC
- NorwayLariamCheplapharm Arzneimittel GmbH
- SwedenLariam 250 mg TablettCheplapharm Arzneimittel GmbH
- FranceLARIAM 250 mg, comprimé sécableCHEPLAPHARM ARZNEIMITTEL (ALLEMAGNE)
- BelgiumLariam 250 mgCheplapharm Arzneimittel
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Austria · Lariam
- Belgium · Lariam
- Cyprus · Eloquine
- Finland · Lariam
- France · Lariam
- Italy · Lariam
- Luxembourg · Lariam
- Netherlands · Lariam
- Norway · Lariam
- Portugal · Mephaquin Lactab
- Sweden · Lariam
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a9ff4cd5-d3fd-400d-b6a2-7d51d7fe4e92 GET /v1/drugs/a9ff4cd5-d3fd-400d-b6a2-7d51d7fe4e92?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "715911000001107",
"desc": "Lariam 250mg tablets (Neon Healthcare Ltd)",
"form": "Oral tablet",
"vpid": "39700111000001106",
"source": "dmd",
"vtm_id": "776655005",
"strength": "250 mg",
"substance": "Mefloquine",
"ingredient": "Mefloquine hydrochloride",
"supplier_code": "36905611000001106"
}See everything about mefloquine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.